108 related articles for article (PubMed ID: 23377523)
1. Two cases of hepatitis B in patients with moderate to severe psoriasis with ustekinumab.
Opel D; Economidi A; Chan D; Wasfi Y; Mistry S; Vergou T; Antoniou C; Sofen H
J Drugs Dermatol; 2012 Dec; 11(12):1498-501. PubMed ID: 23377523
[TBL] [Abstract][Full Text] [Related]
2. The safety profile of ustekinumab in the treatment of patients with psoriasis and concurrent hepatitis B or C.
Chiu HY; Chen CH; Wu MS; Cheng YP; Tsai TF
Br J Dermatol; 2013 Dec; 169(6):1295-303. PubMed ID: 23746170
[TBL] [Abstract][Full Text] [Related]
3. Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting.
Navarro R; Vilarrasa E; Herranz P; Puig L; Bordas X; Carrascosa JM; Taberner R; Ferrán M; García-Bustinduy M; Romero-Maté A; Pedragosa R; García-Diez A; Daudén E
Br J Dermatol; 2013 Mar; 168(3):609-16. PubMed ID: 22985451
[TBL] [Abstract][Full Text] [Related]
4. Risk of Reactivation of Hepatitis B Virus Infection in Psoriasis Patients Treated With Biologics: A Retrospective Analysis of 20 Cases From the BIOBADADERM Database.
Sanz-Bueno J; Vanaclocha F; García-Doval I; Torrado R; Carretero G; Daudén E; Patricia Ruiz-Genao D; Alsina-Gibert MM; Pérez-Zafrilla B; Pérez-Rial G; Rivera R;
Actas Dermosifiliogr; 2015; 106(6):477-82. PubMed ID: 25776200
[TBL] [Abstract][Full Text] [Related]
5. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.
Azadmanesh K; Mohraz M; Aghakhani A; Edalat R; Jam S; Eslamifar A; Banifazl M; Moradmand-Badie B; Ramezani A
Intervirology; 2008; 51(4):270-4. PubMed ID: 18841029
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
7. Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up.
Papp KA; Griffiths CE; Gordon K; Lebwohl M; Szapary PO; Wasfi Y; Chan D; Hsu MC; Ho V; Ghislain PD; Strober B; Reich K; ; ;
Br J Dermatol; 2013 Apr; 168(4):844-54. PubMed ID: 23301632
[TBL] [Abstract][Full Text] [Related]
8. [Differential clinical diagnostic parameters of acute hepatitis B and flare of chronic HBV infection].
Zhao H; Tian GS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):363-5. PubMed ID: 15650791
[TBL] [Abstract][Full Text] [Related]
9. The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection.
Tsai TF; Ho V; Song M; Szapary P; Kato T; Wasfi Y; Li S; Shen YK; Leonardi C;
Br J Dermatol; 2012 Nov; 167(5):1145-52. PubMed ID: 22803615
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus reactivation during therapy with ustekinumab for psoriasis in a hepatitis B surface-antigen-negative anti-HBs-positive patient.
Koskinas J; Tampaki M; Doumba PP; Rallis E
Br J Dermatol; 2013 Mar; 168(3):679-80. PubMed ID: 23121260
[No Abstract] [Full Text] [Related]
11. Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients.
Prignano F; Ricceri F; Pescitelli L; Zanieri F; Lotti T
Br J Dermatol; 2011 Mar; 164(3):645-7. PubMed ID: 21375517
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumor necrosis factor treatment in occult hepatitis B virus infection: a retrospective analysis of 62 patients with psoriatic disease.
Cassano N; Mastrandrea V; Principi M; Loconsole F; De Tullio N; Di Leo A; Vena GA
J Biol Regul Homeost Agents; 2011; 25(2):285-9. PubMed ID: 21880218
[TBL] [Abstract][Full Text] [Related]
13. Liver Injury in Psoriasis Patients Receiving Ustekinumab: A Retrospective Study of 44 Patients Treated in the Clinical Practice Setting.
Llamas-Velasco M; Concha-Garzón MJ; García-Diez A; Daudén E
Actas Dermosifiliogr; 2015; 106(6):470-6. PubMed ID: 25912374
[TBL] [Abstract][Full Text] [Related]
14. Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients.
Wu W; Li J; Chen F; Zhu H; Peng G; Chen Z
J Gastroenterol Hepatol; 2010 Apr; 25(4):750-7. PubMed ID: 20492330
[TBL] [Abstract][Full Text] [Related]
15. Use of anti-tumor necrosis factor-α therapy in hepatitis B virus carriers with psoriasis or psoriatic arthritis: a case series in Taiwan.
Cho YT; Chen CH; Chiu HY; Tsai TF
J Dermatol; 2012 Mar; 39(3):269-73. PubMed ID: 22077677
[TBL] [Abstract][Full Text] [Related]
16. Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use.
Brodmerkel C; Wadman E; Langley RG; Papp KA; Bourcier M; Poulin Y; Ho V; Guenther L; Kunynetz R; Nigen S; Vender R; Wasel N; Hsu MC; Szapary P
J Drugs Dermatol; 2013 Oct; 12(10):1122-9. PubMed ID: 24085047
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantation.
Flowers M; Sherker A; Sinclair SB; Greig PD; Cameron R; Phillips MJ; Blendis L; Chung SW; Levy GA
Transplantation; 1994 Jul; 58(2):183-92. PubMed ID: 8042236
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity.
Kim KH; Ahn SH; Chung HY; Paik YH; Lee KS; Kim YS; Chon CY; Moon YM; Han KH
J Gastroenterol Hepatol; 2004 Aug; 19(8):847-53. PubMed ID: 15242485
[TBL] [Abstract][Full Text] [Related]
19. Dual infection in chronic hepatitis C patients.
Vardareli E; Sariçam T; Ozakyol A; Kircali B; Kasifoglu T
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxcii-ccxciv. PubMed ID: 15244205
[TBL] [Abstract][Full Text] [Related]
20. The use of ustekinumab in a patient with severe psoriasis and positive HBV serology.
Steglich RB; Meneghello LP; Carvalho AV; Cheinquer H; Muller FM; Reginatto FP
An Bras Dermatol; 2014; 89(4):652-4. PubMed ID: 25054756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
